Lisa V5

April 12, 2021

Ms. Lejuwaan brings an extensive background in pharmaceutical and biotech sales, with a particular expertise in launching therapies for rare neurological disorders.

She was most recently Executive Sales Director, Neurology Franchise at Alexion Pharmaceuticals, where she managed a sales team of 56 and was responsible for creation and execution of the overall commercial plan in Alexion’s neurology business unit.
Lisa Lejuwaan has over 25 years of pharmaceutical sales and sales leadership experience. She joined Alexion Pharmaceuticals in 2014 as an account manager for the Atlanta region, quickly moving into sales leadership in Alexion’s neurological franchise, first as Business Director and then as Executive Sales Director. There, she managed sales in two neurological rare diseases, generalized Myasthenia Gravis (gMG) and Neuromyelitis Optica Spectrum Disorder, growing gMG to be the largest overall driver of revenue across Alexion.

Prior to Alexion, Ms. Lejuwaan worked for 13 years with Sanofi Genzyme in a variety of sales, field marketing and sales leadership roles for surgical devices and endocrine therapies. She has also held sales positions in Galena Biopharma, Sankyo Parke Davis, Abbott Laboratories, Mark Clark Medical Supplies, and Astra Pharmaceuticals.
Ms. Lejuwaan holds a B.A. in Political Science and International Business from Kansas State University, Manhattan, KS, where she graduated with honors and is a member of the Phi Beta Kappa and Golden Key honor societies.